BRAIN.Q Email Format
Health and Human ServicesNew Jersey, United States11-50 Employees
BRAIN.Q, based in New Jersey, is developing an evidence-based platform for brain health therapeutics. Its work targets improving brain health and aging-related outcomes, with a focus on reducing disability after stroke and other neurodisorders. The approach has been described as AI-powered, integrating neuroscience advances into a therapeutic platform. In 2021, BrainQ was designated by the FDA as a Breakthrough Device, signaling regulatory interest in accelerating development and potential access to new pathways. With a small-to-mid-sized team, the company serves the health and human services sector, focusing on clinicians and patients affected by stroke and other neurodisorders.